|
Parkhill, Amy L; Bidlack, Jean M (2006) Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line. Int Immunopharmacol 6:1013-9
|
|
Bidlack, Jean M; Khimich, Maxim; Parkhill, Amy L et al. (2006) Opioid receptors and signaling on cells from the immune system. J Neuroimmune Pharmacol 1:260-9
|
|
Gekker, Genya; Hu, Shuxian; Wentland, Mark P et al. (2004) Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther 309:600-6
|
|
Peterson, P K; Gekker, G; Lokensgard, J R et al. (2001) Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol 61:1145-51
|
|
Bidlack, J M; Abraham, M K (2001) Mitogen-induced activation of mouse T cells increases kappa opioid receptor expression. Adv Exp Med Biol 493:103-10
|
|
Martin-Kleiner, I; Bidlack, J M (2001) Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity. Int Immunopharmacol 1:13-20
|
|
Bidlack, J M (2000) Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 7:719-23
|
|
Ignatowski, T A; Bidlack, J M (1999) Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation. J Pharmacol Exp Ther 290:863-70
|
|
Martin-Kleiner, I; Bidlack, J M (1999) The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line. Int J Immunopharmacol 21:133-40
|
|
Ignatowski, T A; Bidlack, J M (1998) Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry. J Pharmacol Exp Ther 284:298-306
|
Showing the most recent 10 out of 24 publications
